John Thipphawong

1.6k total citations
53 papers, 1.2k citations indexed

About

John Thipphawong is a scholar working on Physiology, Pharmacology and Anesthesiology and Pain Medicine. According to data from OpenAlex, John Thipphawong has authored 53 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Physiology, 18 papers in Pharmacology and 17 papers in Anesthesiology and Pain Medicine. Recurrent topics in John Thipphawong's work include Pain Mechanisms and Treatments (25 papers), Pain Management and Opioid Use (17 papers) and Cancer Treatment and Pharmacology (8 papers). John Thipphawong is often cited by papers focused on Pain Mechanisms and Treatments (25 papers), Pain Management and Opioid Use (17 papers) and Cancer Treatment and Pharmacology (8 papers). John Thipphawong collaborates with scholars based in United States, Canada and Belgium. John Thipphawong's co-authors include Kathleen Kelly, Gayatri Sathyan, Mark S. Wallace, Panna Sanga, Iulia Cristina Tudor, Sarita Khanna, Elena Polverejan, Magdi Hanna, Babatunde Otulana and Jüergen Häeussler and has published in prestigious journals such as Neurology, PEDIATRICS and Advanced Drug Delivery Reviews.

In The Last Decade

John Thipphawong

51 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Thipphawong United States 22 402 366 215 193 174 53 1.2k
Antonio Gatti Italy 23 367 0.9× 432 1.2× 298 1.4× 288 1.5× 110 0.6× 53 1.4k
Lesley J. Smith United States 23 214 0.5× 177 0.5× 84 0.4× 173 0.9× 58 0.3× 59 1.3k
Christine Egger United States 22 307 0.8× 151 0.4× 74 0.3× 108 0.6× 42 0.2× 57 1.3k
Giulio Cesare Passàli Italy 27 257 0.6× 677 1.8× 56 0.3× 102 0.5× 124 0.7× 133 2.3k
G. T. D. Thomson Canada 17 112 0.3× 106 0.3× 135 0.6× 72 0.4× 94 0.5× 38 1.4k
Thomas Grau Germany 27 229 0.6× 90 0.2× 147 0.7× 144 0.7× 186 1.1× 56 2.8k
Antonio David Italy 21 166 0.4× 50 0.1× 60 0.3× 160 0.8× 40 0.2× 66 1.3k
Ainsley M. Sutherland Canada 14 103 0.3× 56 0.2× 111 0.5× 226 1.2× 83 0.5× 17 746
Meghan Kirksey United States 13 221 0.5× 76 0.2× 43 0.2× 139 0.7× 72 0.4× 22 991
D W Empey United Kingdom 18 96 0.2× 827 2.3× 44 0.2× 356 1.8× 74 0.4× 52 1.8k

Countries citing papers authored by John Thipphawong

Since Specialization
Citations

This map shows the geographic impact of John Thipphawong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Thipphawong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Thipphawong more than expected).

Fields of papers citing papers by John Thipphawong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Thipphawong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Thipphawong. The network helps show where John Thipphawong may publish in the future.

Co-authorship network of co-authors of John Thipphawong

This figure shows the co-authorship network connecting the top 25 collaborators of John Thipphawong. A scholar is included among the top collaborators of John Thipphawong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Thipphawong. John Thipphawong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kelly, Kathleen, Panna Sanga, Steven Wang, et al.. (2019). Safety and efficacy of fulranumab in osteoarthritis of the hip and knee: results from four early terminated phase III randomized studies. Current Medical Research and Opinion. 35(12). 2117–2127. 16 indexed citations
3.
Wallace, Mark S., Dwight E. Moulin, Richard Rauck, et al.. (2018). Long-term safety, tolerability, and efficacy of OROS® hydromorphone in patients with chronic pain. Journal of Opioid Management. 5(2). 97–105. 1 indexed citations
4.
Slatkin, Neal E., Steven Wang, John D. Louie, et al.. (2018). Fulranumab as Adjunctive Therapy for Cancer-Related Pain: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study. Journal of Pain. 20(4). 440–452. 10 indexed citations
5.
6.
7.
Moskowitz, Roland W., M Lequesne, Michael A. Mont, et al.. (2013). Adjudication process for joint events of interest in fulranumab clinical trial program. Osteoarthritis and Cartilage. 21. S288–S289. 3 indexed citations
8.
Sanga, Panna, Nathaniel P. Katz, Elena Polverejan, et al.. (2013). Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in the treatment of patients with moderate to severe osteoarthritis pain. Pain. 154(10). 1910–1919. 91 indexed citations
9.
Shram, Megan J., Myroslava K. Romach, Edward M. Sellers, & John Thipphawong. (2009). Assessing the abuse potential of an oral osmotic-controlled extended release (OROS) hydromorphone compared to immediate release hydromorphone. Journal of Pain. 10(4). S45–S45. 5 indexed citations
10.
Turgeon, Jacques, R Gröning, Gayatri Sathyan, John Thipphawong, & Ute Richarz. (2009). The pharmacokinetics of a long-acting OROS hydromorphone formulation. Expert Opinion on Drug Delivery. 7(1). 137–144. 15 indexed citations
11.
Hanna, Magdi, et al.. (2008). A randomized, double-blind comparison of OROS®hydromorphone and controlled-release morphine for the control of chronic cancer pain. BMC Palliative Care. 7(1). 17–17. 48 indexed citations
12.
Sathyan, Gayatri, et al.. (2007). Pharmacokinetic investigation of dose proportionality with a 24-hour controlled-release formulation of hydromorphone. PubMed. 7(1). 3–3. 26 indexed citations
13.
14.
Wallace, Mark S., Richard Rauck, Dwight E. Moulin, et al.. (2007). Once-daily OROS® hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study. International Journal of Clinical Practice. 61(10). 1671–1676. 33 indexed citations
15.
16.
Thipphawong, John. (2006). Inhaled cytokines and cytokine antagonists. Advanced Drug Delivery Reviews. 58(9-10). 1089–1105. 19 indexed citations
17.
Davison, Sonia L., John Thipphawong, Jim Blanchard, et al.. (2005). Pharmacokinetics and Acute Safety of Inhaled Testosterone in Postmenopausal Women. The Journal of Clinical Pharmacology. 45(2). 177–184. 30 indexed citations
18.
Otulana, Babatunde, et al.. (2004). Safety and pharmacokinetics of inhaled morphine delivered using the AERx System in patients with moderate-to-severe asthma. International Journal of Clinical Pharmacology and Therapeutics. 42(8). 456–462. 13 indexed citations
19.
Geller, David E., John Thipphawong, Babatunde Otulana, et al.. (2003). Bolus Inhalation of rhDNase with the AERx System in Subjects with Cystic Fibrosis. Journal of Aerosol Medicine. 16(2). 175–182. 18 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio Gatti Breakdown of academic impact, for papers by Lesley J. Smith Breakdown of academic impact, for papers by Christine Egger Breakdown of academic impact, for papers by Giulio Cesare Passàli Breakdown of academic impact, for papers by G. T. D. Thomson Breakdown of academic impact, for papers by Thomas Grau Breakdown of academic impact, for papers by Antonio David Breakdown of academic impact, for papers by Ainsley M. Sutherland Breakdown of academic impact, for papers by Meghan Kirksey Breakdown of academic impact, for papers by D W Empey
Rankless by CCL
2026